Xanthohumol Restores Hepatic Glucolipid Metabolism Balance in Type 1 Diabetic Wistar Rats.

Abstract

Diabetes exhibits increased inflammation, angiogenesis, and apoptosis, three processes attenuated by xanthohumol (XN). Herein, we evaluate the effect of XN-enriched stout beer consumption in hepatic glucolipid metabolism imbalance seen in type 1 diabetes (T1D). Five groups of Wistar rats were established: streptozotocin-induced diabetic rats drinking water, treated with 5% ethanol, stout beer, and stout beer supplemented with 10 mg of XN/L and healthy rats drinking water. Hepatic periodic acid-Schiff, reticulin, sirius red, and oil red O histological staining was performed. Lipogenic enzymes and glucose transporter 2 (GLUT2) expression was evaluated by western blotting. Increased fibrosis in T1D animals was significantly decreased to control levels by XN (3.85 ± 0.38 in T1D-beer versus 1.78 ± 0.27 in controls, p < 0.05; 2.27 ± 0.69 in T1D-beer + XN versus 1.78 ± 0.27 in controls, p > 0.05). XN reduced T1D hepatic reticulin staining (9.74 ± 3.78 in T1D-beer, p < 0.05 versus control) to healthy levels (4.45 ± 1.05 in T1D-beer + XN versus 4.60 ± 0.20 in healthy controls, p > 0.05). XN consumption interfered with the T1D liver catabolic state, reversing glycogen depletion (22.09 ± 7.70 in T1D-beer + XN versus 4.68 ± 4.84 in T1D-beer, p < 0.05) and GLUT2 upregulation (1.71 ± 0.46 in T1D-beer + XN versus 2.13 ± 0.34 in T1D-beer, p < 0.05) and enhancing lipogenesis (1.19 ± 0.11 in T1D-beer + XN versus 1.96 ± 0.36 in T1D, p < 0.05 for acetyl-CoA carboxylase; 1.10 ± 0.04 in T1D-beer + XN versus 0.44 ± 0.31 in T1D, p < 0.05 for fatty acid synthase). These findings reveal that XN can be a therapeutic agent against liver metabolic changes in T1D, playing a possible role in the insulin receptor pathways.

• Authors: Mário Lima-Fontes, Raquel Costa, Ilda Rodrigues, Raquel Soares
• Journal: Journal of agricultural and food chemistry (J Agric Food Chem) Vol. 65 Issue 34 Pg. 7433-7439 (Aug 30 2017) ISSN: 1520-5118 [Electronic] United States
• PMID: 28745504 (Publication Type: Journal Article)

Chemical References

• Flavonoids
• Glucose Transporter Type 2
• Propiophenones
• Glucose
• xanthohumol

Topics

• Animals
• Diabetes Mellitus, Type 1 (drug therapy, genetics, metabolism)
• Flavonoids (administration & dosage)
• Glucose (metabolism)
• Glucose Transporter Type 2 (genetics, metabolism)
• Humans
• Lipid Metabolism (drug effects)
• Liver (drug effects, metabolism)
• Male
• Propiophenones (administration & dosage)
• Rats
• Rats, Wistar